Company page

Brightgene Bio-medical Technology Co. Ltd. Class A

Brightgene Bio-medical Technology Co. Ltd. Class A, trading under the ticker 688166, is a public company based in China. With a market capitalization of approximately 2.78 billion USD, the company focuses on advancements in the biomedical sector. Brightgene is committed to developing innovative solutions to enhance healthcare outcomes.

profile688166:SSEAI content: aiUpdated June 24, 2026/company/brightgene-bio-medical-technology-c/c-snfj7vwh
Brightgene Bio-medical Technology Co. Ltd. Class A logo
Ticker
688166:SSE
Asset type
Stock
Market cap
$2.78B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
SSE
Currency
CNY